The Global Warm Autoimmune Hemolytic Anemia (WAIHA) Treatment Industry, valued at US$ 638.96 Million in 2023, is set to experience unprecedented growth, reaching a staggering US$ 1598 Million by the year 2033. This impressive trajectory is driven by a robust Compound Annual Growth Rate (CAGR) of 9.6% between 2023 an.
Apellis Pharmaceuticals (NASDAQ:APLS) Raised to Buy at Jefferies Financial Group themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
February is Age-related Macular Degeneration (AMD) and Low Vision Awareness Month urbanacitizen.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urbanacitizen.com Daily Mail and Mail on Sunday newspapers.
Equities Research Analysts’ updated eps estimates for Tuesday, February 6th: Apellis Pharmaceuticals (NASDAQ:APLS) had its outperform rating reissued by analysts at Robert W. Baird. They currently have a $81.00 target price on the stock. BeiGene (NASDAQ:BGNE) had its overweight rating reissued by analysts at JPMorgan Chase & Co.. They currently have a $185.00 price target […]
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report)‘s stock had its “outperform” rating reiterated by Robert W. Baird in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $81.00 price target on the stock. Robert W. Baird’s target price points to a potential upside of 21.68% from the stock’s previous close. […]